$150 Million Raised By Medical Company For HRAS Cancer Treatment

Kura Oncology Raises $150 Million in Oversubscribed Private Placement: A Game-Changer in Cancer Treatment?

Disclaimer: This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.

In a significant development in the field of oncology, Kura Oncology, Inc., a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, rec…